MD-reviewed ·  Healthcare editorial
MedAI Verdict
Mental health

Reference AS-130  ·  AI Mental Health

Rosebud

by Rosebud Health

ACT-based AI journaling with reflection prompts.

Visit RosebudRead our methodology

At a glance

Pricing
~$8.99/mo.
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
—

Independent score  ·  By our public rubric

12/100Tracked
How it’s computed →
  • Regulatory & Compliance
    0/25

    No FDA clearance listed

  • Clinical Integration
    0/13

    No EHR integrations listed

  • Evidence Strength
    5.6/20

    1 peer-reviewed paper

  • Vendor & Market
    3/18

    market_relevance=45 (seed or unfunded)

  • Sentiment & Transparency
    2.5/18.5

    1 pricing tier(s) but no $ amounts (contact-sales pattern)

▸ Show all 11 dimensions

Regulatory & Compliance

  • FDA clearance0/12

    No FDA clearance listed

  • HIPAA / SOC2 / BAA0/13

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/7

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/4

    None of the top-3 EHRs covered

  • Bidirectional write-back0/2

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers6/14

    1 peer-reviewed paper

  • RCT / meta-analysis / systematic review0/6

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal3/12

    market_relevance=45 (seed or unfunded)

  • Years in market0/6

    Founded year not recorded

Sentiment & Transparency

  • Clinician sentiment (Reddit)0/14

    No clinician sentiment data available

  • Pricing transparency3/5

    1 pricing tier(s) but no $ amounts (contact-sales pattern)

Last computed May 26, 2026 · Rubric v1.0.0

Bottom line

ACT-based AI journaling with reflection prompts.

Free tier available.

Editorial review pending

We do not yet have enough independent sources for Rosebud to publish a full editorial review. A complete review requires peer-reviewed coverage, clinician sentiment from public forums, or hands-on testing notes from our editorial team.

The vendor overview below reflects what we have verified from the vendor and from our category-level reporting. When additional sources surface, the review is regenerated automatically and dated. If you have direct hands-on experience and want to share it on the record, write to editorial@medaiverdict.com.

Overview

ACT-based journaling app with AI reflection prompts. Affiliate-program available.

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

TierMonthlyAnnualNotes
Plan——~$8.99/mo.

Source: vendor pricing page. Verified July 3, 2026.

Peer-reviewed coverage

What the literature says

1 peer-reviewed study indexed on PubMed evaluate Rosebud in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.

Personal Strategies for DIEP Flap Breast Reconstruction in Patients with Prior Abdominal Surgery and Hernia Repairs.
Gupta S, Arora R, Mishra K, et al.· Arch Plast Surg· 2026
Delayed breast reconstruction using deep inferior epigastric perforator (DIEP) flaps in patients with a history of abdominal wall hernias and/or cesarean sections presents unique challenges. This study examines 10 such cases, emphasizing key technical considerations. Our findings highlight the importance of lateral row perforators, as medial paraumbilical perforators are often compromised in patients with prior umbilical hernia repairs. Additionally, deep inferior epigastric arteries (DIEAs) may be damaged in previous lower abdominal surgeries, necessitating intraoperative confirmation of ves…

See all on PubMed

In the same category

Other mental health

See the full mental health ranking